These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16002258)

  • 1. Vector-primed mice display hypo-responsiveness to foreign antigen presented by recombinant Salmonella regardless of the route of delivery.
    Attridge SR; Vindurampulle CJ
    Microb Pathog; 2005; 39(1-2):1-7. PubMed ID: 16002258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines.
    Vindurampulle CJ; Attridge SR
    Infect Immun; 2003 Jan; 71(1):287-97. PubMed ID: 12496178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prior immunological exposure on vaccine delivery by Salmonella enterica serovar Typhimurium.
    Gahan ME; Webster DE; Wijburg OL; Wesselingh SL; Strugnell RA
    Vaccine; 2008 Nov; 26(49):6212-20. PubMed ID: 18852007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy.
    Vindurampulle CJ; Cuberos LF; Barry EM; Pasetti MF; Levine MM
    Vaccine; 2004 Sep; 22(27-28):3744-50. PubMed ID: 15315855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular adjuvant mC3d enhances the immunogenicity of FimA from type I fimbriae of Salmonella enterica serovar Enteritidis.
    Musa HH; Zhang WJ; Lv J; Duan XL; Yang Y; Zhu CH; Li HF; Chen KW; Meng X; Zhu GQ
    J Microbiol Immunol Infect; 2014 Feb; 47(1):57-62. PubMed ID: 23352331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
    Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization of attenuated Salmonella C500 strain with a delta asd mutant and use as an Asd+ balanced-lethal host-vector system].
    Zhao Z; Xu Y; Wu B; Cheng X; Li Y; Tang X; Zhang C; Chen H
    Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):29-36. PubMed ID: 19441223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain.
    Attridge SR; Davies R; LaBrooy JT
    Vaccine; 1997 Feb; 15(2):155-62. PubMed ID: 9066032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vector priming reduces the immunogenicity of Salmonella-based vaccines in Nramp1+/+ mice.
    Vindurampulle CJ; Attridge SR
    Infect Immun; 2003 Apr; 71(4):2258-61. PubMed ID: 12654852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosting systemic and secreted antibody responses in mice orally immunized with recombinant Bacillus subtilis strains following parenteral priming with a DNA vaccine encoding the enterotoxigenic Escherichia coli (ETEC) CFA/I fimbriae B subunit.
    Luiz WB; Cavalcante RC; Paccez JD; Souza RD; Sbrogio-Almeida ME; Ferreira RC; Ferreira LC
    Vaccine; 2008 Jul; 26(32):3998-4005. PubMed ID: 18597902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica.
    Zhao Z; Xue Y; Wu B; Tang X; Hu R; Xu Y; Guo A; Chen H
    Infect Immun; 2008 May; 76(5):2157-63. PubMed ID: 18268026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new concept to stimulate mucosal as well as systemic immunity by parenteral vaccination as applied to the development of a live attenuated Salmonella enterica serovar Dublin vaccine.
    Mizuno T; Ploeg R; Trott D
    Vet Res; 2007; 38(6):773-94. PubMed ID: 17727804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of mice with live oral vaccine based on a Salmonella enterica (sv Typhimurium) aroA strain expressing the Escherichia coli O111 O antigen.
    Wang L; Curd H; Reeves PR
    Microb Pathog; 1999 Jul; 27(1):55-9. PubMed ID: 10371709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a Porphyromonas gingivalis hemagglutinin on the surface of a Salmonella vaccine vector.
    Isoda R; Simanski SP; Pathangey L; Stone AE; Brown TA
    Vaccine; 2007 Jan; 25(1):117-26. PubMed ID: 16942819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge.
    Liu WT; Lin WT; Tsai CC; Chuang CC; Liao CL; Lin HC; Hung YW; Huang SS; Liang CC; Hsu HL; Wang HJ; Liu YT
    Vaccine; 2006 Jul; 24(31-32):5852-61. PubMed ID: 16759760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA response of BALB/c mice to orally administered Salmonella typhimurium flagellin-displaying T2 bacteriophages.
    Synnott A; Ohshima K; Nakai Y; Tanji Y
    Biotechnol Prog; 2009; 25(2):552-8. PubMed ID: 19334277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in mice.
    Chen AY; Fry SR; Forbes-Faulkner J; Daggard GE; Mukkur TK
    Vet Microbiol; 2006 May; 114(3-4):252-9. PubMed ID: 16426773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired mucosal immunity in L-selectin-deficient mice orally immunized with a Salmonella vaccine vector.
    Pascual DW; White MD; Larson T; Walters N
    J Immunol; 2001 Jul; 167(1):407-15. PubMed ID: 11418677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.